SARDA PROTEINS LTD.

Sarda Proteins Ltd has announced the closure of its trading window for dealing in the company's securities. This restriction will be in effect from Wednesday, July 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. The closure applies to designated persons, including directors, key managerial personnel, identified employees, and promoters, along with their immediate relatives, in compliance with SEBI's insider trading regulations. The date of the board meeting to approve these financial results will be communicated separately.

The Independent Directors Committee (IDC) of Sarda Proteins Ltd has submitted its recommendations to the BSE regarding the open offer made by M/s Onix Renewable Limited and associated Persons Acting in Concert (PACs) to public shareholders. The offer aims to acquire up to 17,30,400 equity shares, representing 19.28% of the company's emerging voting share capital, at an offer price of ₹115 per share. The IDC's recommendations, published in various newspapers, will guide public shareholders on the offer's fairness and reasonableness. This filing is a crucial step in the open offer process, providing an independent assessment.

Grow House Wealth Management Pvt Ltd, acting as the 'Manager to the Offer', has submitted a Letter of Offer to the Public Shareholders of Sarda Proteins Ltd. This open offer is being made by Onix Renewable Limited, along with PACs (Divyeshkumar Mansukhbhai Savaliya, Piyush Mansukhbhai Savaliya, and Nikhil Hareshbhai Savaliya), for the acquisition of 17,30,400 equity shares, representing 19.28% of the voting share capital. The offer price is set at ₹115.00 per share. This acquisition is pursuant to SEBI (SAST) Regulations, 2011, for substantial acquisition of shares and voting rights accompanied by a change in control and management of Sarda Proteins Ltd.

Sarda Proteins Ltd's Board of Directors approved the standalone audited financial results for the quarter and financial year ended March 31, 2026. For the full financial year 2026, the company reported a total revenue of ₹2,419.17 Lakhs and a profit of ₹0.50 Lakhs. In the fourth quarter ended March 31, 2026, the company recorded a total revenue of ₹89.3 Lakhs and incurred a loss of ₹11.81 Lakhs. The results, including Cash Flow and Assets Liabilities Statements, were approved with an unmodified audit opinion.

Sarda Proteins Ltd has announced that its Board of Directors will convene a meeting on Thursday, April 30, 2026. The primary agenda for this meeting is to consider and approve the standalone Audited financial results for the quarter and financial year ended March 31, 2026. In line with regulatory requirements, the trading window for dealing in the company's securities has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of these financial results.

Onix Renewable Limited, formerly known as Onix Structure Private Limited, through its appointed Manager Grow House Wealth Management Pvt Ltd, has announced an Open Offer for acquisition of up to 17,30,400 fully paid-up equity shares of Sarda Proteins Ltd, representing 19.28% of the company's emerging voting share capital on a fully diluted basis. The Offer Price is set at Rs. 115.00 per Equity Share. The Offer is triggered in compliance with the provisions of Regulations 3 (1), and 4 of the SEBI (SAST) Regulations, pursuant to the proposed Conversion of warrant into Equity Shares of 72,50,000 fully paid-up Equity Shares on preferential basis.

Sarda Proteins Ltd has announced the closure of the trading window for designated persons and their immediate relatives. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from 1st April, 2026 until the end of 48 hours after the declaration of audited financial results for the quarter and year ending on 31st March, 2026. The date of the board meeting for the consideration and declaration of these results will be intimated in due course.

Grow House Wealth Management Pvt Ltd, as the Manager to the Offer, has submitted a Detailed Public Statement to BSE regarding the acquisition of up to 17,30,400 fully paid-up equity shares of Sarda Proteins Ltd by Onix Renewable, Divyesh Mansukhbhai Savaliya, Piyush Mansukhbhai Savaliya, and Nikhil Hareeshbhai Savaliya. The acquisition represents 19.28% of the emerging voting share capital of Sarda Proteins Ltd on a fully diluted basis. The offer is made in compliance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended. The offer price is Rs. 115.00 (+ premium of Rs. 105.00) per offer share, payable in cash.

Onix Renewable Ltd has acquired 70,00,000 shares of Sarda Proteins Limited, which amounts to 77.99% of the total voting capital. This acquisition was made on the Bombay Stock Exchange Limited. Before the acquisition, Onix Renewable along with PACs held no shares or voting rights in Sarda Proteins. The acquisition was made through preferential allotment upon conversion of issue shares.

Sarda Proteins Ltd has received an open offer from Onix Renewable Limited (formerly known as Onix Structure Private Limited) along with Divyesh Mansukhbhai Savaliya and Piyush Mansukhbhai Savaliya for the acquisition of up to 17,30,400 fully paid-up equity shares, representing 19.28% of the emerging voting share capital of Sarda Proteins Ltd on a fully diluted basis. The offer price is set at Rs. 115.00 per equity share. This offer is being made pursuant to and in compliance with Regulations 3(1) and 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011.